These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9111291)

  • 1. Inhibition of uridine phosphorylase. Synthesis and structure-activity relationships of aryl-substituted 1-((2-hydroxyethoxy)methyl)-5-(3-phenoxybenzyl)uracil.
    Orr GF; Musso DL; Kelley JL; Joyner SS; Davis ST; Baccanari DP
    J Med Chem; 1997 Apr; 40(8):1179-85. PubMed ID: 9111291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of uridine phosphorylase: synthesis and structure-activity relationships of aryl-substituted 5-benzyluracils and 1-[(2-hydroxyethoxy)methyl]-5-benzyluracils.
    Orr GF; Musso DL; Boswell GE; Kelley JL; Joyner SS; Davis ST; Baccanari DP
    J Med Chem; 1995 Sep; 38(19):3850-6. PubMed ID: 7562916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 2: optimization of inhibitors of human thymidine phosphorylase and their selectivity with uridine phosphorylase.
    Yano S; Kazuno H; Sato T; Suzuki N; Emura T; Wierzba K; Yamashita J; Tada Y; Yamada Y; Fukushima M; Asao T
    Bioorg Med Chem; 2004 Jul; 12(13):3443-50. PubMed ID: 15186830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine, potent inhibitors of uridine phosphorylase.
    Niedzwicki JG; Chu SH; el Kouni MH; Rowe EC; Cha S
    Biochem Pharmacol; 1982 May; 31(10):1857-61. PubMed ID: 7104017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of 5-benzylacyclouridine, a potent inhibitor of uridine phosphorylase, on the metabolism of circulating uridine by the isolated rat liver.
    Monks A; Ayers O; Cysyk RL
    Biochem Pharmacol; 1983 Jul; 32(13):2003-9. PubMed ID: 6870929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory potency of 5-benzyluracil, 5-phenylcytosine and 5-phenylpyrimidin-2-one nucleosides against uridine phosphorylase from mouse leukemic L1210 cells.
    Votruba I; Krecmerová M; Hrebabecký H; Holý A
    Nucleosides Nucleotides; 1999; 18(11-12):2551-64. PubMed ID: 10639754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of 5-benzylacyclouridine, an inhibitor of uridine phosphorylase, on the pharmacokinetics of uridine in rhesus monkeys: implications for chemotherapy.
    Sommadossi JP; Cretton EM; Kidd LB; McClure HM; Anderson DC; el Kouni MH
    Cancer Chemother Pharmacol; 1995; 37(1-2):14-22. PubMed ID: 7497584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-Benzylbarbituric acid derivatives, potent and specific inhibitors of uridine phosphorylase.
    Naguib FN; Levesque DL; Wang EC; Panzica RP; el Kouni MH
    Biochem Pharmacol; 1993 Oct; 46(7):1273-83. PubMed ID: 8216379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression, characterization, and detection of human uridine phosphorylase and identification of variant uridine phosphorolytic activity in selected human tumors.
    Liu M; Cao D; Russell R; Handschumacher RE; Pizzorno G
    Cancer Res; 1998 Dec; 58(23):5418-24. PubMed ID: 9850074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I clinical and pharmacological studies of benzylacyclouridine, a uridine phosphorylase inhibitor.
    Pizzorno G; Yee L; Burtness BA; Marsh JC; Darnowski JW; Chu MY; Chu SH; Chu E; Leffert JJ; Handschumacher RE; Calabresi P
    Clin Cancer Res; 1998 May; 4(5):1165-75. PubMed ID: 9607574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Species-dependent differences in the biochemical effects and metabolism of 5-benzylacyclouridine.
    Davis ST; Joyner SS; Chandrasurin P; Baccanari DP
    Biochem Pharmacol; 1993 Jan; 45(1):173-81. PubMed ID: 8424810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of plasma uridine concentration by 5-(phenylselenenyl)acyclouridine, an inhibitor of uridine phosphorylase: relevance to chemotherapy.
    Ashour OM; Al Safarjalani ON; Naguib FN; Goudgaon NM; Schinazi RF; el Kouni MH
    Cancer Chemother Pharmacol; 2000; 45(5):351-61. PubMed ID: 10803917
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of nucleoside transport in murine lymphoma L5178Y cells and human erythrocytes by the uridine phosphorylase inhibitors 5-benzylacyclouridine and 5-benzyloxybenzylacyclouridine.
    Lee KH; el Kouni MH; Chu HS; Cha S
    Cancer Res; 1984 Sep; 44(9):3744-8. PubMed ID: 6744292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tissue-specific expansion of uridine pools in mice. Effects of benzylacyclouridine, dipyridamole and exogenous uridine.
    Darnowski JW; Handschumacher RE; Wiegand RA; Goulette FA; Calabresi P
    Biochem Pharmacol; 1991 Jun; 41(12):2031-6. PubMed ID: 2039551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for inhibition of Escherichia coli uridine phosphorylase by 5-substituted acyclouridines.
    Bu W; Settembre EC; el Kouni MH; Ealick SE
    Acta Crystallogr D Biol Crystallogr; 2005 Jul; 61(Pt 7):863-72. PubMed ID: 15983408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of oral uridine as a substitute for parenteral uridine rescue of 5-fluorouracil therapy, with and without the uridine phosphorylase inhibitor 5-benzylacyclouridine.
    Martin DS; Stolfi RL; Sawyer RC
    Cancer Chemother Pharmacol; 1989; 24(1):9-14. PubMed ID: 2720896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 1: discovery of novel orally active inhibitors of human thymidine phosphorylase.
    Yano S; Kazuno H; Suzuki N; Emura T; Wierzba K; Yamashita J; Tada Y; Yamada Y; Fukushima M; Asao T
    Bioorg Med Chem; 2004 Jul; 12(13):3431-41. PubMed ID: 15186829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New analogues of benzylacyclouridines, specific and potent inhibitors of uridine phosphorylase from human and mouse livers.
    Naguib FN; el Kouni MH; Chu SH; Cha S
    Biochem Pharmacol; 1987 Jul; 36(13):2195-201. PubMed ID: 3606636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and synthesis of novel 5,6-disubstituted uracil derivatives as potent inhibitors of thymidine phosphorylase.
    Nencka R; Votruba I; Hrebabecký H; Tloust'ová E; Horská K; Masojídková M; Holý A
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1335-7. PubMed ID: 16337119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzylacyclouridine. Pharmacokinetics, metabolism and biochemical effects in mice.
    Darnowski JW; Handschumacher RE
    Biochem Pharmacol; 1988 Jul; 37(13):2613-8. PubMed ID: 3390221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.